European Commission 30 June 2026, Commission Implementing Decision (EU) 2026/1420 of 30 June 2026 on the non-approval of terbutryn, 1,2-Benzisothiazol-3(2H)-one (BIT) and tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) as existing active substances for use in biocidal products of product-types 9, 9, and 12, respectively, in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Also known as
European Union · · · Cited by 1 · 30-06-2026
Official Journal
of the European Union
EN
L series
2026/1420
3.7.2026
COMMISSION IMPLEMENTING DECISION (EU) 2026/1420
of 30 June 2026
on the non-approval of terbutryn, 1,2-Benzisothiazol-3(2H)-one (BIT) and tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) as existing active substances for use in biocidal products of
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (1 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit